COVID-19 Impact on Blood Transfusion Devices Market, Global Research Reports 2020-2021

    • ID: AR2933297
    • 27 May, 2020
    • Other
    • Region: Global
    • 95 Pages
    • QYResearch

  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Blood Transfusion Devices Industry
  • 1.7 COVID-19 Impact: Blood Transfusion Devices Market Trends
  • 2 Global Blood Transfusion Devices Quarterly Market Size Analysis

    • 2.1 Blood Transfusion Devices Business Impact Assessment - COVID-19
      • 2.1.1 Global Blood Transfusion Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Blood Transfusion Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Blood Transfusion Devices Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Blood Transfusion Devices Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Blood Transfusion Devices Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Blood Transfusion Devices Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Blood Transfusion Devices Market
    • 3.5 Key Manufacturers Blood Transfusion Devices Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Blood Transfusion Devices Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Blood Collection
      • 1.4.2 Blood Processing
      • 1.4.3 Blood Safety
      • 1.4.4 Other
    • 4.2 By Type, Global Blood Transfusion Devices Market Size, 2019-2021
      • 4.2.1 By Type, Global Blood Transfusion Devices Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Blood Transfusion Devices Price, 2020-2021

    5 Impact of Covid-19 on Blood Transfusion Devices Segments, By Application

    • 5.1 Overview
      • 5.5.1 Blood Collection
      • 5.5.2 Blood Processing
      • 5.5.3 Blood Safety
      • 5.5.4 Other
    • 5.2 By Application, Global Blood Transfusion Devices Market Size, 2019-2021
      • 5.2.1 By Application, Global Blood Transfusion Devices Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Blood Transfusion Devices Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Macopharma
      • 7.1.1 Macopharma Business Overview
      • 7.1.2 Macopharma Blood Transfusion Devices Quarterly Production and Revenue, 2020
      • 7.1.3 Macopharma Blood Transfusion Devices Product Introduction
      • 7.1.4 Macopharma Response to COVID-19 and Related Developments
    • 7.2 Becton Dickinson
      • 7.2.1 Becton Dickinson Business Overview
      • 7.2.2 Becton Dickinson Blood Transfusion Devices Quarterly Production and Revenue, 2020
      • 7.2.3 Becton Dickinson Blood Transfusion Devices Product Introduction
      • 7.2.4 Becton Dickinson Response to COVID-19 and Related Developments
    • 7.3 B.Braun
      • 7.3.1 B.Braun Business Overview
      • 7.3.2 B.Braun Blood Transfusion Devices Quarterly Production and Revenue, 2020
      • 7.3.3 B.Braun Blood Transfusion Devices Product Introduction
      • 7.3.4 B.Braun Response to COVID-19 and Related Developments
    • 7.4 Terumo
      • 7.4.1 Terumo Business Overview
      • 7.4.2 Terumo Blood Transfusion Devices Quarterly Production and Revenue, 2020
      • 7.4.3 Terumo Blood Transfusion Devices Product Introduction
      • 7.4.4 Terumo Response to COVID-19 and Related Developments
    • 7.5 Abbott
      • 7.5.1 Abbott Business Overview
      • 7.5.2 Abbott Blood Transfusion Devices Quarterly Production and Revenue, 2020
      • 7.5.3 Abbott Blood Transfusion Devices Product Introduction
      • 7.5.4 Abbott Response to COVID-19 and Related Developments
    • 7.6 Haemonetics
      • 7.6.1 Haemonetics Business Overview
      • 7.6.2 Haemonetics Blood Transfusion Devices Quarterly Production and Revenue, 2020
      • 7.6.3 Haemonetics Blood Transfusion Devices Product Introduction
      • 7.6.4 Haemonetics Response to COVID-19 and Related Developments
    • 7.7 Fresenius Kabi
      • 7.7.1 Fresenius Kabi Business Overview
      • 7.7.2 Fresenius Kabi Blood Transfusion Devices Quarterly Production and Revenue, 2020
      • 7.7.3 Fresenius Kabi Blood Transfusion Devices Product Introduction
      • 7.7.4 Fresenius Kabi Response to COVID-19 and Related Developments
    • 7.8 Immucor
      • 7.8.1 Immucor Business Overview
      • 7.8.2 Immucor Blood Transfusion Devices Quarterly Production and Revenue, 2020
      • 7.8.3 Immucor Blood Transfusion Devices Product Introduction
      • 7.8.4 Immucor Response to COVID-19 and Related Developments
    • 7.9 Fenwal
      • 7.9.1 Fenwal Business Overview
      • 7.9.2 Fenwal Blood Transfusion Devices Quarterly Production and Revenue, 2020
      • 7.9.3 Fenwal Blood Transfusion Devices Product Introduction
      • 7.9.4 Fenwal Response to COVID-19 and Related Developments
    • 7.10 Qmed
      • 7.10.1 Qmed Business Overview
      • 7.10.2 Qmed Blood Transfusion Devices Quarterly Production and Revenue, 2020
      • 7.10.3 Qmed Blood Transfusion Devices Product Introduction
      • 7.10.4 Qmed Response to COVID-19 and Related Developments
    • 7.11 Cerus
      • 7.11.1 Cerus Business Overview
      • 7.11.2 Cerus Blood Transfusion Devices Quarterly Production and Revenue, 2020
      • 7.11.3 Cerus Blood Transfusion Devices Product Introduction
      • 7.11.4 Cerus Response to COVID-19 and Related Developments
    • 7.12 Haemonetics
      • 7.12.1 Haemonetics Business Overview
      • 7.12.2 Haemonetics Blood Transfusion Devices Quarterly Production and Revenue, 2020
      • 7.12.3 Haemonetics Blood Transfusion Devices Product Introduction
      • 7.12.4 Haemonetics Response to COVID-19 and Related Developments
    • 7.13 Chindex Medical Limited
      • 7.13.1 Chindex Medical Limited Business Overview
      • 7.13.2 Chindex Medical Limited Blood Transfusion Devices Quarterly Production and Revenue, 2020
      • 7.13.3 Chindex Medical Limited Blood Transfusion Devices Product Introduction
      • 7.13.4 Chindex Medical Limited Response to COVID-19 and Related Developments
    • 7.14 Armstrong Medical
      • 7.14.1 Armstrong Medical Business Overview
      • 7.14.2 Armstrong Medical Blood Transfusion Devices Quarterly Production and Revenue, 2020
      • 7.14.3 Armstrong Medical Blood Transfusion Devices Product Introduction
      • 7.14.4 Armstrong Medical Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Blood Transfusion Devices Supply Chain Analysis
      • 8.1.1 Blood Transfusion Devices Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Blood Transfusion Devices Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Blood Transfusion Devices Distribution Channels
      • 8.2.2 Covid-19 Impact on Blood Transfusion Devices Distribution Channels
      • 8.2.3 Blood Transfusion Devices Distributors
    • 8.3 Blood Transfusion Devices Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Blood Transfusion Devices, including the following market information:
      Global Blood Transfusion Devices Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Blood Transfusion Devices Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Blood Transfusion Devices Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Blood Transfusion Devices Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Macopharma, Becton Dickinson, B.Braun, Terumo, Abbott, Haemonetics, Fresenius Kabi, Immucor, Fenwal, Qmed, Cerus, Haemonetics, Chindex Medical Limited, Armstrong Medical, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Blood Collection
      Blood Processing
      Blood Safety
      Other

      Based on the Application:
      Blood Collection
      Blood Processing
      Blood Safety
      Other



      Summary:
      Blood Transfusion Devices Market Research Report is about Blood Transfusion Devices Industry study. Get complete Blood Transfusion Devices market research report published after Market Study, Industrial Analysis with Trends & Statistics. Blood Transfusion Devices Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED